Skip to main content
. Author manuscript; available in PMC: 2009 Sep 15.
Published in final edited form as: Cancer Res. 2008 Sep 15;68(18):7403–7408. doi: 10.1158/0008-5472.CAN-08-1449

Figure 4.

Figure 4

Oncrasin-induced aggregation of PKCι T29, T29Kt1, and H460 cells were treated with DMSO or 10 μM (for T29 or T29Kt1) or 1 μM (for H460) oncrasin-1 for 12 hours, and then immunofluorescent staining was performed to test for intracellular localization of PKCι. Nuclear PKCι aggregated into large foci after oncrasin-1 treatment in sensitive T29Kt1 and H460 cells but not in the resistant T29 cells.